Related by context. Frequent words. (Click for all words.) 71 Calls Purchased 70 PYMX 69 Inc Therapeutic Competitors 69 Bearish Pressure Building 68 Q3 Loss Narrows 68 NASDAQ CRXL 68 F#Q# Qtr End 68 Stock Upgraded 66 Q2 Loss Narrows 66 Q1 Loss Narrows 66 NovaBay Pharmaceuticals Inc. 66 Idera Pharmaceuticals 66 www.otc advisors.com names 66 Healthnostics Inc. 66 Q2 Loss Widens 66 THE TREND CONTINUES LOWER 66 Webcast Annual Meeting 65 Interesting Options Volume 65 RELEASES ITS QUARTERLY NUMBERS 65 Options Trader Alert 65 Guides FY# Quick Facts 65 Stock Downgraded 65 Genaera Corporation 65 Trend Continues Down 65 Host Fourth Quarter 65 Presents Positive 65 Company Nasdaq PRGO 65 Pink Sheets INTK 65 Looks Bullish 65 Novelos Therapeutics Inc. 65 Schedules Fiscal 65 SHARES COULD POTENTIALLY PULLBACK 65 Hold Fourth Quarter 65 CEO Exercises Options 65 Detects Unusual Activity 65 THE TREND CONTINUES DOWN 64 Downtrend Spotted 64 Files Annual Report 64 VIA Pharmaceuticals 64 Host Third Quarter 64 Announces Organizational Changes 64 Posts Large Volume 64 Bullish Engulfing Pattern 64 BROOMFIELD Colo. BUSINESS WIRE 64 WEEK HIGH RECENTLY ECLIPSED 64 Declares Regular Quarterly 64 Immunicon Corporation 64 Inc. NasdaqGM 64 Nasdaq ALTH 64 IIROC Halt 64 Q4 Loss Narrows 64 SMARTREND RESEARCH REPORT AVAILABLE 64 ShamrockStocks.com Lucky Picks 64 Xethanol Corporation 64 Skymark Research Initiates Independent 64 PROFILE CO 64 Bearish Harami Pattern 63 SGMO 63 THE ISSUER IS AUTHORITATIVE 63 Q1 Loss Widens 63 Holds Annual Meeting 63 Cloud Cover Pattern 63 Q3 Loss Widens 63 Trend Continues Lower 63 Sees Continued Downward Momentum 63 'S SHARES CHANGING 63 #.#X ABOVE AVERAGE VOLUME 63 Host Second Quarter 63 Pluristem Therapeutics Inc. 63 Winning Streak Continues 63 Posts Large 63 Axxess Pharma Inc. 63 THE TREND CONTINUES UP 63 SET TO POSSIBLY PULLBACK 63 Sunesis Pharmaceuticals Inc. 63 WATERTOWN Mass. BUSINESS WIRE 63 Q4 Loss Widens 63 ALIM 63 Bullish Pressure 63 Announces Additions 63 #/#/# PriceWatch Alert Technicals [001] 63 Earnings Scorecard 63 SET TO REBOUND AFTER 63 LOOKS TO CONTINUE TO 63 Q3 Profit Surges 63 SmarTrend Option Scanner 63 HIGHER PRICES ON #.#X 63 www.syntapharma.com 63 Recent Trades 63 OFFERS INVESTORS BETTER VALUE 63 QGEN 63 REACHES INITIAL SUPPORT LEVEL 63 www.labopharm.com 63 www.combinatorx.com 63 BULLISH MOVING AVERAGE CROSSOVER 63 THE TREND CONTINUES HIGHER 63 VOLUME WATCH FOR 63 UPTREND SPOTTED IN SHARES 62 Skystar Bio Pharmaceutical 62 Adopts Shareholder Rights 62 quotes/comstock/# *